11 May, 2009 – 20:04 | 7 Comments

In an about-face to their stance during the Clinton Administration, leaders of the nation’s healthcare industry have promised to cut prices in response to the Obama Administration’s vow to resolve the healthcare crisis and make health care available to every…

Read the full story »
Diet

Drugs

Lifestyle

Medical Research

Prevention

Home » Archive by Category

Articles in Drugs

‘Holy Grail’ of Prostate Cancer Revealed, Stocks Soar
23 June, 2009 – 17:14 | No Comment

Investors are flocking to buy shares of biopharmaceutical company, Medarex, Inc. (MEDX), after an announcement from the Mayo Clinic revealed a new drug, manufactured by Medarex, has helped cure two men of prostate cancer tumors that were once too large…

Some Zicam Cold Remedies Increase Risk of Permanent Loss of Smell
20 June, 2009 – 10:27 | 3 Comments

Hundreds of Americans are thought to be at risk of permanent loss of smell after taking particular homeopathic remedies that contain zinc and are marketed under the brand name, Zicam.  Because anosmia, the medical term for loss of smell, can…

No More Walgreen Medicaid Prescriptions in Delaware
5 June, 2009 – 7:31 | No Comment

In a move that seems to repeat its recent actions in Washington state, Walgreen Company has announced it will no longer be filling prescriptions for Medicaid patients in the state of Delaware.  The pharmacy chain, the largest in the state,…

Empty Pockets Meant Slow Prescription Drug Sales in 2008
29 May, 2009 – 7:28 | No Comment

Empty American pockets don’t contain the money needed to buy prescription drugs as lavishly as in recent years, a cold and hard fact that meant prescription drug sales slowed to a crawl in 2008.  The paltry 1.3% increase over 2007’s…

Cancer Treatment Erases Tourist’s Fingerprints, Leads to Airport Detention
28 May, 2009 – 23:08 | No Comment

The current issue of the Annals of Oncology carries the story of a cancer patient from Singapore who met with detention as a suspected security risk when he arrived at an airport in the United States to visit relatives in…

Baxter Int’l Redux? Two Delaware Deaths Linked to Heparin
12 May, 2009 – 11:08 | No Comment

Two deaths in Delaware are linked to the premixed intravenous (IV) bags of heparin administered to them in recent days.  A third patient suffered adverse effects, too, but has survived the ordeal, according to Erin Gardiner, a spokesperson for Baxter…

Botox Much More Than Just a Pretty Face
16 April, 2009 – 5:09 | 2 Comments

The mere mention of the word Botox brings to mind fixed expressions on fading celebrity faces but not everyone who uses the cosmetic injections go to those extremes.  When used with discretion, Botox does an excellent job of making those…

FDA Says 14 Unapproved Narcotic Painkillers Must Go
11 April, 2009 – 15:52 | One Comment

Almost 2% of all prescriptions filled in the United States are for drugs that never got approval from the US Food and Drug Administration (FDA).  Fourteen of these unapproved drugs are for narcotic painkillers that the FDA says must go…

Doctor Accused of Fabricating Drug Safety Data
17 March, 2009 – 13:31 | No Comment

The American public relies on the US Food and Drug Administration (FDA) to ensure nothing but the safest drugs are prescribed but the FDA relies on medical research scientists to provide the background data in order to approve or deny…

Supreme Court Rules Against Wyeth in Amputation Case
5 March, 2009 – 23:20 | 2 Comments

In a precedent-setting ruling, the US Supreme Court sided with the victim in a case of bodily injury caused by unlabeled side effects against the drug’s manufacturer.  The drug maker, Wyeth Pharmaceuticals, of Madison, New Jersey, claimed it could not…

FDA Approves First New Gout Drug in 40 Years
16 February, 2009 – 23:51 | 5 Comments

It’s been 40 years since the US Food and Drug Administration (FDA) approved a new drug for treating gout but the new drug, Uloric (febuxostat), has just passed the test, according to Takeda Pharmaceuticals, maker of Uloric.  A daily dose…

Eli Lilly Gets $1.4B Fine for Zyprexa Off-Label Marketing
6 February, 2009 – 11:18 | 3 Comments

The US Justice Department has ordered Eli Lilly and Company to pay penalties totaling $1.415 billion for off-label marketing of its drug, Zyprexa.  The company pleaded guilty on January 30 to a misdemeanor charge of marketing the drug for unapproved…

List of Drugs Getting FDA Safety Review
6 February, 2009 – 7:27 | One Comment

The US Food and Drug Administration (FDA) has released a list of dozens of drugs for which it is conducting safety reviews after concerns over their side effects and potential complications have been raised.  Some of the drugs under scrutiny…

Vicks VapoRub May Do More Harm Than Good To Youngest Children
3 February, 2009 – 22:02 | No Comment

For generations, Vicks VapoRub has been considered a medicine-cabinet staple but a report published in the medical journal, ‘Chest,’ says the youngest children in the household should not use this popular cold remedy.   In fact, for infants and toddlers, it…